Pulmatrix Receives $3,500,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f1a9a5f-ce10-4715-b3a3-bc47443ebc2e&Preview=1 -
Date
2/22/2013 -
Company Name
Pulmatrix -
Mailing Address
99 Hayden Avenue Lexington, MA 02421 -
Company Description
Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination. -
Website
http://www.pulmatrix.com -
Transaction Type
Debt -
Transaction Amount
$3,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended. -
M&A Terms
-
Venture Investor
Undisclosed
